These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9034700)

  • 41. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Manipulation of mental competence: an ethical problem in case of electrical stimulation of the subthalamic nucleus for severe Parkinson's disease].
    Verslegers WR; van den Kerchove M; de Deyn PP
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1997-8; author reply 1998. PubMed ID: 15524138
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation scales for Parkinson's disease].
    Krystkowiak P
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():52-62. PubMed ID: 10916037
    [No Abstract]   [Full Text] [Related]  

  • 45. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.
    Bailine S; Kremen N; Kohen I; Linder H; Schwartz GJ; Mogilner AY; Pourfar M
    J ECT; 2008 Jun; 24(2):171-2. PubMed ID: 18580566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Electroconvulsive treatment in parkinsonism].
    Arsland D; Larsen JP; Tandberg E
    Tidsskr Nor Laegeforen; 1993 Nov; 113(29):3564-6. PubMed ID: 8273093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The basal ganglia and inhibitory mechanisms in response selection: evidence from subliminal priming of motor responses in Parkinson's disease.
    Seiss E; Praamstra P
    Brain; 2004 Feb; 127(Pt 2):330-9. PubMed ID: 14645146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A longitudinal study of neuropsychological change in individuals with Parkinson's disease.
    Azuma T; Cruz RF; Bayles KA; Tomoeda CK; Montgomery EB
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1115-20. PubMed ID: 14677144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of ECT in Parkinson's disease.
    Birkett DP
    Am J Psychiatry; 1990 Jul; 147(7):952. PubMed ID: 2356887
    [No Abstract]   [Full Text] [Related]  

  • 50. ECT, opioid system, and motor response in Parkinson's disease .
    Sandyk R
    Biol Psychiatry; 1986 Feb; 21(2):235-6. PubMed ID: 3004611
    [No Abstract]   [Full Text] [Related]  

  • 51. ECT, opioids, and motility in Parkinson's disease.
    Sandyk R
    Biol Psychiatry; 1986 Apr; 21(4):428-9. PubMed ID: 3955122
    [No Abstract]   [Full Text] [Related]  

  • 52. Acceptability of electroconvulsive therapy to patients with Parkinson's disease.
    Ismail K; Howard R; Lovestone S
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):383-4. PubMed ID: 8158197
    [No Abstract]   [Full Text] [Related]  

  • 53. Electroconvulsive therapy in Parkinson's disease: 30 month follow up.
    Pridmore S; Pollard C
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):693. PubMed ID: 8648342
    [No Abstract]   [Full Text] [Related]  

  • 54. Improvement of depression and parkinsonism during ECT: a case study.
    Dysken M; Evans HM; Chan CH; Davis JM
    Neuropsychobiology; 1976; 2(2-3):81-6. PubMed ID: 1012451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Author response.
    Odekerken VJ; Boel JA; Schmand BA; de Bie RM
    Neurology; 2015 Oct; 85(16):1433-4. PubMed ID: 26771041
    [No Abstract]   [Full Text] [Related]  

  • 56. [Convulsive electrotherapy in Parkinson disease. Presentation of a clinical case].
    Barrientos N; Chaná P; Ramírez M; Díaz F
    Rev Med Chil; 1992 Jan; 120(1):59-61. PubMed ID: 1305313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parkinson's disease.
    Milroy TM
    CMAJ; 1989 Jun; 140(11):1268. PubMed ID: 2720509
    [No Abstract]   [Full Text] [Related]  

  • 58. Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder.
    Pridmore S; Yeo PT; Pasha MI
    J Neurol Neurosurg Psychiatry; 1995 May; 58(5):641-2. PubMed ID: 7745424
    [No Abstract]   [Full Text] [Related]  

  • 59. Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis.
    Yudofsky SC
    Compr Psychiatry; 1979; 20(6):579-81. PubMed ID: 41677
    [No Abstract]   [Full Text] [Related]  

  • 60. Parkinson's disease.
    Fitzgerald K; Devakumar M
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):392. PubMed ID: 7897435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.